Beta-adrenergic blocking drugs

Annu Rev Med. 1985:36:145-64. doi: 10.1146/annurev.me.36.020185.001045.

Abstract

There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenoceptor drugs can be rationally used to a therapeutic advantage.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / pharmacology*
  • Adrenergic beta-Antagonists / therapeutic use
  • Angina Pectoris / drug therapy
  • Arrhythmias, Cardiac / drug therapy
  • Chemical Phenomena
  • Chemistry
  • Heart / drug effects
  • Heart Block / chemically induced
  • Heart Failure / chemically induced
  • Humans
  • Hypertension / drug therapy
  • Ion Channels / drug effects
  • Kinetics
  • Lipids
  • Myocardial Infarction / prevention & control
  • Raynaud Disease / chemically induced
  • Sodium / metabolism
  • Substance Withdrawal Syndrome

Substances

  • Adrenergic beta-Antagonists
  • Ion Channels
  • Lipids
  • Sodium